Aurora Sheboygan Prices – Panitumumab 100 Milligrams Per 5 Milliliters Intravenous Solution

Panitumumab is an advanced intravenous medication primarily used in the treatment of certain cancers, such as colorectal cancer. At Aurora Medical Center Sheboygan County, the cost for Panitumumab is $649.61 per unit (100 mg per 5 mL). This fee typically covers the medication itself and may include preparation and administration by clinical staff, but does not always encompass additional facility, pharmacy, or professional service charges. Patients are advised to request detailed, itemized estimates from the facility to clarify all potential costs, including associated fees for infusion services, facility use, and physician supervision.

Cost Breakdown

• Medication Cost: $649.61 per 100 mg/5 mL unit
• Administration Fees: May be charged separately for IV infusion services
• Facility Fees: Additional costs may apply for use of infusion suites or hospital resources
• Pharmacy Fees: Preparation and handling charges could be included or billed separately
• Physician/Professional Fees: Oncologist or supervising physician charges may apply

Associated Costs to Consider

• Pre-infusion lab tests (e.g., blood work)
• Supportive medications (such as anti-nausea drugs or steroids)
• Follow-up visits and monitoring
• Potential management of side effects or complications

Insurance & Payment Advice

• Check with your insurance provider to confirm coverage for Panitumumab and associated infusion services.
• Ask about prior authorization requirements, co-pays, coinsurance, and deductibles.
• Inquire about financial assistance programs or manufacturer patient support if you are uninsured or underinsured.
• Request an itemized estimate before each treatment cycle to avoid unexpected bills.

Side-Effect Considerations

• Common side effects may include skin rash, diarrhea, fatigue, and infusion reactions.
• Discuss potential side effects and management strategies with your oncology team prior to starting therapy.
• Promptly report any adverse effects to your healthcare provider to ensure proper management.

Recovery Tips

• Stay hydrated and maintain a balanced diet to support recovery during cancer treatment.
• Keep all scheduled follow-up appointments for monitoring and lab work.
• Contact your care team promptly if you experience any new or worsening symptoms.
• Ask about supportive care resources, such as counseling or nutrition services, offered by the facility.

Frequently Asked Questions

• What is Panitumumab and what is it used for?
  Panitumumab is a targeted cancer therapy used primarily to treat certain types of colorectal cancer by inhibiting proteins that help cancer cells grow.
• How is Panitumumab administered?
  It is given as an intravenous infusion, typically in a hospital or infusion center under professional supervision.
• What does the $649.61 fee include?
  This price covers the medication per 100 mg/5 mL vial; other services like infusion, facility, or physician fees may be billed separately.
• Will my insurance cover Panitumumab treatment?
  Coverage varies; check with your insurer about authorization, out-of-pocket costs, and any required documentation.
• Are there additional costs beyond the listed medication price?
  Yes, expect possible charges for infusion services, facility use, lab tests, and provider fees.
• How often will I need Panitumumab infusions?
  The frequency depends on your specific cancer type, stage, and treatment plan—your oncologist will provide a schedule.
• What side effects should I watch for during treatment?
  Common side effects include rash, diarrhea, and fatigue. Report any severe or concerning symptoms to your healthcare team.
• Can I get financial assistance for this treatment?
  Ask about hospital financial counseling, manufacturer patient programs, or non-profit support if you need help with costs.
• How can I reduce my out-of-pocket expenses?
  Review your insurance plan, use in-network providers, and request itemized bills to identify and address billing errors.
• What should I do before my infusion appointment?
  Follow any instructions from your care team, such as fasting, hydration, or medication adjustments, and bring a list of current medications.
• How do I prepare for possible side effects?
  Discuss prevention and management strategies with your provider, and have necessary medications or supplies at home as advised.

Aurora Medical Center Sheboygan County offers a range of medical services, including specialized treatments such as Panitumumab, an intravenous solution used primarily in oncology for the treatment of certain types of cancer. This medication, administered at a dosage of 100 milligrams per 5 milliliters, is priced at $649.61 per unit at the Aurora Sheboygan facility. Panitumumab works by targeting and inhibiting specific proteins that promote cancer cell growth, thereby helping to manage and control the progression of the disease. The cost reflects the complexity and specificity of the treatment, which is tailored to meet the needs of patients undergoing cancer therapy.

What is Panitumumab used for? – Panitumumab is used in the treatment of certain types of cancer, particularly colorectal cancer, by targeting and inhibiting proteins that contribute to cancer cell growth.

How is Panitumumab administered? – Panitumumab is administered as an intravenous solution, meaning it is delivered directly into the bloodstream through a vein, typically in a clinical setting.

What is the cost of Panitumumab at Aurora Medical Center Sheboygan County? – The cost of Panitumumab at Aurora Medical Center Sheboygan County is $649.61 for a dosage of 100 milligrams per 5 milliliters.

Are there any side effects associated with Panitumumab? – Yes, Panitumumab may cause side effects, including skin rash, fatigue, nausea, and diarrhea, among others; patients should discuss potential side effects with their healthcare provider.

Is Panitumumab covered by insurance? – Coverage for Panitumumab varies by insurance provider and plan; patients should check with their insurance company to determine if the medication is covered under their policy.

How does Panitumumab work? – Panitumumab works by binding to and inhibiting the epidermal growth factor receptor (EGFR), which is involved in the growth and spread of cancer cells.

Who is eligible to receive Panitumumab treatment? – Eligibility for Panitumumab treatment is determined by a healthcare provider based on the patient’s specific cancer type, stage, and overall health condition.

Can Panitumumab be used in combination with other treatments? – Yes, Panitumumab is often used in combination with other cancer treatments, such as chemotherapy, to enhance its effectiveness; treatment plans should be discussed with a healthcare provider.